Rare EGFR and KRAS mutations and tumor response to EGFR TKI.
收藏数据链接：
官方服务：
资源简介：
PR is partial response, PD is progressive disease, – = no EGFR TKI treatment; (E) = erlotinib, (G) = gefitinib, ND = Not described.
创建时间：
2015-12-02
社区交流群
科研交流群
商业服务
PR is partial response, PD is progressive disease, – = no EGFR TKI treatment; (E) = erlotinib, (G) = gefitinib, ND = Not described.